A Phase 1, Multi-Center, Open-Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SL889 in Adult Patients with Stable Sickle Cell Disease

Project: Research project

Project Details

Description

A Phase 1, Multi-Center, Open-Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SL889 in Adult Patients with Stable Sickle Cell Disease
StatusActive
Effective start/end date7/10/197/31/20

Funding

  • CSL BEHRING GMBH

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.